The full name of the monosialic acid medication is called tetrahexose ganglioside sodium monosialate injection, and it can be used for neurological injuries, with variations in the corresponding course of treatment. For central nervous system injuries, it is usually used for 6 weeks. If it is used for Parkinson’s disease, the relative course of treatment is longer, about 18 weeks. Monosialic acid medication is mainly used for the treatment of diseases of the central nervous system and can be used for vascular or traumatic central nervous system injuries, as well as for the treatment of Parkinson’s disease. This drug is used for different diseases and the corresponding course of treatment varies. Generally, in the acute phase of nerve injury, especially traumatic nerve injury, the recommended usage is to change to a maintenance dose after 2-3 weeks, and if it is used for the treatment of Parkinson’s disease, the first dose is high, and it is changed to a smaller dose from the next day onwards. In the literature, the use of monosialic acid in various animals during pregnancy and lactation has not shown any adverse effects. If a pregnant woman needs to take this product, she should follow her doctor’s advice before deciding whether to take it.